Bonhaus D W, Berger J, Adham N, Branchek T A, Hsu S A, Loury D N, Leung E, Wong E H, Clark R D, Eglen R M
Neurobiology Unit, Roche Bioscience, Palo Alto, CA 94303, USA.
Neuropharmacology. 1997 Apr-May;36(4-5):671-9. doi: 10.1016/s0028-3908(97)00039-7.
RS 57639, by being a partial agonist in rat esophagus but a competitive antagonist in guinea-pig ileum, is one of several ligands which operationally discriminate among 5-HT4 receptors in different tissues. The discovery of splice variants of the 5-HT4 receptor, 5-HT4S and 5-HT4L, raises the possibility that this functional heterogeneity among 5-HT4 receptors may be due to differences in the interaction of ligands with different isoforms of the receptor. To test this idea, the functional and binding interactions of RS 57639 with rat 5-HT4S and 5-HT4L receptors were characterized. RS 57639 stimulated adenylate cyclase in cells expressing 5-HT4S or 5-HT4L receptors with similar potency (pEC50 = 7.9 +/- 0.1 and 7.6 +/- 0.1) and efficacy (71 +/- 3 and 59 +/- 4% of 5-HT). [3H]RS 57639 also bound to 5-HT4S and 5-HT4L receptors with similar affinity (Kd = 0.09 +/- 0.01 and 0.11 +/- 0.01 nM) and specificity (SB204070 > GR113808 > SDZ 205557 > cisapride > renzapride > alpha me-5-HT > 5-CT). Therefore, the operational differences among 5-HT4 receptors, detected with RS 57639, are not explained by differences in the interaction of the ligand with 5-HT4S and 5-HT4L receptors. [3H]RS 57639 binding to guinea-pig striatal membranes was also characterized. [3H]RS 57639 bound with high affinity (Kd = 0.25 +/- 0.07 nM) and a specificity similar to that of the 5-HT4 receptor antagonist, [3H]GR113808. Therefore, while the mechanism by which RS 57639 operationally distinguishes among 5-HT4 receptors was not determined, [3H]RS 57639 was shown to specifically label native and cloned 5-HT4 receptors. As the first selective agonist radioligand to be described for this receptor, [3H]RS 57639 may prove useful in further studies of receptor coupling and ligand interactions.
RS 57639在大鼠食管中是部分激动剂,但在豚鼠回肠中是竞争性拮抗剂,它是在不同组织中对5-羟色胺4(5-HT4)受体进行有效区分的几种配体之一。5-HT4受体剪接变体5-HT4S和5-HT4L的发现,增加了5-HT4受体之间这种功能异质性可能是由于配体与受体不同亚型相互作用存在差异的可能性。为了验证这一想法,对RS 57639与大鼠5-HT4S和5-HT4L受体的功能及结合相互作用进行了表征。RS 57639以相似的效力(pEC50 = 7.9 +/- 0.1和7.6 +/- 0.1)和效能(分别为5-羟色胺的71 +/- 3%和59 +/- 4%)刺激表达5-HT4S或5-HT4L受体的细胞中的腺苷酸环化酶。[3H]RS 57639也以相似的亲和力(Kd = 0.09 +/- 0.01和0.11 +/- 0.01 nM)和特异性(SB20,4070 > GR113,808 > SDZ 205,557 > 西沙必利 > 瑞扎必利 > α-甲基-5-羟色胺 > 5-羧色胺)与5-HT4S和5-HT4L受体结合。因此,用RS 57639检测到的5-HT4受体之间的功能差异,不能用配体与5-HT4S和5-HT4L受体相互作用的差异来解释。还对[3H]RS 57639与豚鼠纹状体膜的结合进行了表征。[3H]RS 57639以高亲和力(Kd = 0.25 +/- 0.07 nM)结合,且特异性与5-HT4受体拮抗剂[3H]GR113,808相似。因此,虽然尚未确定RS 57639在功能上区分5-HT4受体的机制,但已证明[3H]RS 57639能特异性标记天然和克隆的5-HT4受体。作为首个针对该受体描述的选择性激动剂放射性配体,[3H]RS 57639可能在受体偶联和配体相互作用的进一步研究中有用。